nivolumab,lenvatinib,pembrolizumab,sunitinib,ipilimumab
merck,bms,pfizer,eisai
['clear trial', 'rcc,(-irccs),(-srcc),(-urcc)', 'titan-rcc']
updated results from the #clear trial and the final results of #titan-rcc discussion. presentation by kate young, md . #esmo22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology